Susquehanna Portfolio Strategies »

Enanta Pharmaceuticals shares owned by Susquehanna Portfolio Strategies

Quarter-by-quarter ownership of Enanta Pharmaceuticals (ENTA) shares owned by Susquehanna Portfolio Strategies from 13F filings

Historical chart of Susquehanna Portfolio Strategies investment in Enanta Pharmaceuticals

Tip: Access up to 7 years of quarterly data

All positions including Enanta Pharmaceuticals held by Susquehanna Portfolio Strategies consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Enanta Pharmaceuticals by Susquehanna Portfolio Strategies

Quarter filed Position value Share count Share price at filing
2026-06-30 $251k 17k 14.58

More positions owned by Susquehanna Portfolio Strategies

Intel Corporation (INTC)
Abbvie (ABBV)
Sherwin-Williams Company (SHW)
Medtronic SHS (MDT)
Philip Morris International (PM)
Starbucks Corporation (SBUX)
Costco Wholesale Corporation (COST)
Humana (HUM)
Prologis (PLD)
Williams Companies (WMB)
Devon Energy Corporation (DVN)
Equinix (EQIX)
Metropcs Communications (TMUS)
Monster Beverage Corp (MNST)
Cigna Corp (CI)

View all positions for Susquehanna Portfolio Strategies

Top funds holding Enanta Pharmaceuticals

Henderson Group
Jupiter Topco
BlackRock
Krensavage Asset Management
Farallon Capital Management
Deep Track Capital
ADAR1 Capital Management
Vanguard Capital Management
Spruce Street Capital
Acadian Asset Management
Vanguard Portfolio Management
Geode Capital Management
Millennium Management
State Street Corporation
Renaissance Technologies

View all funds holding Enanta Pharmaceuticals